Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway

Mostrar otras versiones (1)

The effect of paclitaxel combined with lobaplatin on the sensitivity of lung cancer cell line NCI-H446 through influencing the phosphatidylinositol 3-kinase (PI3K)/Akt pathway was investigated. The sensitivity of lobaplatin to NCI-H446 and the effect of paclitaxel and PI3K inhibitor LY294002 combine...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Dongjie, Li, Shanqing, Cui, Yushang, Li, Li, Liu, Hongsheng, Chen, Yeye, Zhou, Xiaoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876435/
https://www.ncbi.nlm.nih.gov/pubmed/29616103
http://dx.doi.org/10.3892/ol.2018.8086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876435/
https://www.ncbi.nlm.nih.gov/pubmed/29616103
http://dx.doi.org/10.3892/ol.2018.8086

Ejemplares similares